Ali contended that UMass waived its sovereign immunity when it accepted funds from the federal government under the University and Small Business Patent Procedures Act, )
35 U.S.C. §§ 200)
12 (2012), commonly known as the Bayh-Dole Act, in support of certain research that led to the issuance of the patents)

(NO.CIV.A. 11-10739, CIV.A. 13-11336)

In general.Bayh-Dole Act, which provides protections against nonuse and unreasonable use of publicly funded inventions, does not create a private right of action. )
35 U.S.C.A. § 200 et seq)
.[6]13 Action 13I Grounds and Conditions Precedent 13 3 k. Statutory rights of action.Federal courts infer a private)

of its licensees sought to sue for patent infringement.''Nutrition 21, 930 F.2d at 866 FN2. In 1980, Congress passed the Bayh-Dole Act, )
35 U.S.C. §§ 200)
212. The Bayh-Dole Act was passed ''to promote the utilization of inventions arising from federally supported research'' and to ''ensure that)

related to it under Bayh–Dole Act, and thus exclusive license to licensee was valid, as would support licensee's standing to bring patent infringement action. )
35 U.S.C.A. § 200)
291 Patents 291X Patents Enumerated 291 2091 k. In general; utility.(Formerly 291k328(2)US Patent 5,560,360 US Patent 5,706,813. Cited.Andrew D)

Act Drugs developed, at least in part, with federal funding are subject to what is commonly referred to as the Bayh–Dole Act (''the Act''), )
35 U.S.C. §§ 200 et seq)
. The Act is designed ''to ensure that the Government obtains sufficient rights in federally supported inventions to meet the needs)

manufacture and distribute Fabrazyme in the United States and Plaintiff contends that the BayhDole Act requires Genzyme to make Fabrazyme ''reasonably accessible to the public.'' )
35 U.S.C. § 200(b)(5)
)However, even if Genzyme's failure to produce sufficient quantities of Fabrazyme was deemed to be an affirmative act of misfeasance)

the patents-in-suit, any patents resulting from that funding fall within the purview of the Bayh–Dole University and Small Business Patent Procedures Act, )
35 U.S.C. § 200 et seq)
. (''Bayh–Dole Act'' or ''Act''). With respect to the patents-in-suit, Ali argues that UMass ''made a clear declaration)

Lab (''NRL'' or ''Navy'') and that the UT System failed to follow the required transfer protocol on government-funded inventions under the Bayh–Dole Act, )
35 U.S.C. § 200 et seq)
. The Bayh–Dole Act requires title to inventions flowing from government-funded research to remain with the government in certain)

arising from federally supported research,''''promote collaboration between commercial concerns and nonprofit organizations,'' and ''ensure that the Government obtains sufficient rights in federally supported inventions.'' )
35 U.S.C. § 200)
. To achieve these aims, the Act allocates rights in federally funded ''subject invention[s]'' between the Federal Government and federal contractors (''any)

at 841–42, 848–49.FN6. In addition to its discussion of statute of limitations issues, Roche concerned the construction of the Bayh–Dole Act, )
35 U.S.C. §§ 200 et seq)
. See Roche, 583 F.3d at 844–45. The Supreme Court granted certiorari to consider this portion of the decision)

Board of Regents was required (but failed) to comply with the applicable transfer protocol for government-funded inventions set forth under the Bayh–Dole Act, )
35 U.S.C. § 200, et seq)
.Id.The Texas Motion to Dismiss has been fully briefed and is awaiting adjudication by Judge Ward.Also pending before)

FOIL; and if disclosed, would cause substantial injury to the PI's competitive efforts FN9. In this connection, OMH notes that under the Bayh–Dole Act, )
35 USC § 200 et seq)
., recipients of federal funding may obtain exclusive rights in inventions derived therefrom for the purpose of further development and commercialization)

conveying to institution a right to sublicense the mouse, which would have conveyed to institution a license covering the mouse. West's Ann.Cal. Const. Art. 3 )
35 U.S.C.A. §§ 200)
207 Joseph Diamante Kenneth E. Keller Michael David Lisi Ronald Marc Daignault, for Plaintiff.Chelsea A Loughran Howard Alan Slavitt Michael A)

inventions arising from the jointly sponsored research to the Foundation. Alternatively, the Foundation claimed it had title to the compounds under the Bayh–Dole Act, )
35 U.S.C. §§ 200 et seq)
., because federal funds had been used in the research and development of the compounds.Relations between Xenon and the Foundation)

(NO.1:07-CV1610 OWWSMS)

Discretion.In addition to challenging the validity of the Patents themselves, Plaintiffs allege that the USDA's licensing activities violate provisions of the Bayh–Dole Act, )
35 U.S.C. § 200 et seq)
. Defendants argue that these licensing claims are barred by Section 701(a)(2) of the APA, which precludes application of)

Dole Act is to regulate relationships of small business and nonprofit grantees with the government, not between grantees and the inventors who work for them. )
35 U.S.C.A. §§ 200)
202[25]95 Contracts 95I Requisites and Validity 95I(F) Legality of Object and of Consideration 95 115 Restraint of Trade or)

(NO.SACV08-0718DOC(RNBX))

terminating the License, respectively. [Counterclaim ¶¶ 58-102.] Network moves to dismiss these counterclaims contending that they are all ''predicated upon the Bayh-Dole Act, )
35 U.S.C. §§ 200)
212 [but] there is no private right of action under the Bayh-Dole Act that gives rise to the claims.''[Mot. at)

Congress could also pass legislation augmenting or undermining incentives for innovation that affect the value of drug patents.See, e.g., Bayh–Dole Act of 1980, )
35 U.S.C. §§ 200)
212 (permitting public universities to enter into exclusive license agreements with private companies); Drug Price Competition and Patent Term Restoration Act, Pub.L)

prices ranging from $1 million to $1.3 million.FN1. The Bayh–Dole Act, also known as the University and Small Business Patent Procedures Act, )
35 U.S.C. §§ 200)
211, provides universities, small businesses, and non-profit organizations with intellectual property control over their inventions arising from federal government-funded research)

would grant the writ to resolve the issue.The Bayh-Dole Act The district court held that ''the legal requirements of the Bayh-Dole Act, )
35 U.S.C. §§ 200)
212, mandated that Stanford be given a superior right to retain title to the patents.''The court ruled that because of Bayh)

panel left the impression that it was giving away this court's jurisdiction over a broad swath of claims potentially arising from the Bayh-Dole Act, )
35 U.S.C. §§ 200)
212 While non-precedential, the panel's opinion nonetheless unnecessarily suggests that this court's jurisdiction to review these cases is limited. I respectfully)

providing Court of Appeals for the Federal Circuit exclusive jurisdiction of appeal from a case arising under federal patent law. 28 U.S.C.A. § 1295(a) )
35 U.S.C.A. § 200 et seq)
.[2]170B Federal Courts 170BIV Cases ''Arising Under'' Federal Law; Federal-Question Jurisdiction 170BIV(E) Objections, Proceedings, and Determination 170B)

him, arguing that he is the rightful owner of the ′538 patent, and that Analytica's claims against him are preempted by the Bayh–Doyle Act,) 35 U.S.C. § 200 et seq) .3 At oral argument, Fenn's counsel conceded that these arguments are precluded by this court's holding, affirmed by the Second)

result of the government-funded research, does not alter the general rule that title to a patent vests in the inventor or the designated assignee. )
35 U.S.C.A. § 200 et seq)
.[28]291 Patents 291VI Patent Rights and Duties 291VI(F) Government Rights and Duties as to Inventions 291 1532 Inventions)

by Roche. Id. at *15.However, the court further held that Holodniy had no interest to assign to Cetus based on the Bayh-Dole Act, )
35 U.S.C. sections 200)
et seq., and therefore the assignment provision of the agreement was void as it applied to the patents-in-suit. Id. The)

grant, retained title to the patent and his exclusive license to licensee was valid; thus, inventor and licensee had standing to bring patent infringement action. )
35 U.S.C.A. §§ 200)
212[3]291 Patents 291IV Patent Applications and Proceedings 291IV(G) Postissuance Proceedings 291IV(G)1 In General 291 1183 k. Certificate of)

merit in Plaintiff's argument that the cited cases are no longer applicable because FAR 52.227–11 has its foundation in the Bayh–Dole Act, )
35 U.S.C. §§ 200)
212 (2000), which effected a change in law regarding how the federal government secures a license under a government contract. Congress passed)

itself from litigation by accepting license form from faculty member did not support any inference that NIH had determined faculty member actually owned the patent. )
35 U.S.C.A. §§ 200 et seq)
.,202(c, d)Appeal from the United States District Court for the District of Connecticut (Christopher F. Droney, Judge).AFTER)

contends that the Government has a license to practice or have practiced on its behalf the '103 and '994 Patents under the Bayh–Dole Act, )
35 U.S.C. § 200, et seq)
., because the inventions described in the '103 and '994 Patents were originally developed as part of Government-sponsored research. Duke)

on the argument that Dr. Buckberg failed to perfect his title to the invention due to his failure to comply with the Bayh-Dole Act, )
35 U.S.C.A. §§ 200)
12, the related agency regulations, and the requirements in the NIH's waiver of patent rights that Buckberg execute a license in favor)

Notice of Removal ¶ 12.) Penn claimed that ''[w]ithout expressly stating so, this Complaint claims a breach of the obligations of the Bayh-Dole Act, )
35 U.S.C. § 200)
et seq., which provides the statutory basis for technology transfer practices and obligations with respect to inventions discovered with federal funding.''Id)

strength and expansion of our national economy. In 1980, Congress passed the Patent and Trademark Act Amendments, commonly referred to as the Bayh-Dole Act, )
35 U.S.C.A. §§ 200)
to 212, to provide federal funding for academic research. The statute was ''enacted to foster commercial development of government funded research.''Platzer)

it because it does not own U.S. Patent Nos. 6,090,543 and 6,348,314 ('543 patent and '314 patent) Defendant argued that under the Bayh-Dole Act, )
35 U.S.C. §§ 200)
212, the University of Wisconsin or the federal government is the rightful owner of both patents. I denied defendant's motion to dismiss)

within two months after invention was disclosed to contractor personnel responsible for patent matters, entitling government to take title to the invention under the FAR. )
35 U.S.C.A. § 200)
48 C.F.R. § 52.227–11(c)(1), (d)[2]316H Public Contracts 316HIX Performance or Breach 316H 357 Decisions of Contracting)

within two months after invention was disclosed to contractor personnel responsible for patent matters, entitling government to take title to the invention under the FAR. )
35 U.S.C.A. § 200)
48 C.F.R. § 52.227–11(c)(1), (d)[2]316H Public Contracts 316HIX Performance or Breach 316H 357 Decisions of Contracting)

(NO.CIV.A.3:96 CV 1647, CIV.A.3:96 CV 736 (C, CIV.A.3:96 CV 990 (C)

13I Grounds and Conditions Precedent 13 3 k. Statutory rights of action.No private cause of action exists to enforce provisions of Bayh-Dole Act. )
35 U.S.C.A. § 200 et seq)
.[7]170B Federal Courts 170BVI Controversies Between Citizens of Different States; Diversity Jurisdiction 170BVI(B) Particular Cases, Contexts, and Questions)

infringement. See 28 U.S.C. § 1498 1 Second, Duke asserts what it characterizes as the ''government license defense.'' Duke claims under the Bayh–Dole Act, )
35 U.S.C. §§ 200)
212, that because ''essentially all of Duke's allegedly infringing activities consist of research being conducted either pursuant to government research grants or)

public,'' and that:Congress has determined that licensing of academia's inventions to industry is the best way to bring groundbreaking inventions to the public.See )
35 U.S.C. § 200)
By vesting in universities the patent rights to their federally funded research, the Bayh–Dole Act of 1980 encouraged ''private industry to)

on the Markert Committee.FN6. The Bayh–Dole Act, Act of Dec. 12, 1980, Pub.L. 96–517, § 6(a), 94 Stat. 3019, codified at )
35 U.S.C. § 200 et seq)
., grants non-profit organizations exclusive title to inventions developed through federal funding, and allows them to freely license such inventions)

stage for modern university licensing, went into effect less than six months before the 634 patent's filing date.'' 196 F.3d at 1374 (citing )
35 U.S.C. § 200 (1994))
While it is of little import in this case where my findings, specifically, are that the University of Colorado was ahead)

the CRADA to the outside party at the outset of the collaboration without going through the standard licensing regulations required by the Bayh–Dole Act, )
35 U.S.C. § 200)
Id. Many of these ''Intramural'' and ''CRADA'' inventions are ''early stage technologies'' that otherwise would not be further developed but for the)

that are covered by such a license are not subject to infringement liability.3 FN3. Such a conclusion is supported by the Bayh–Dole Act, )
35 U.S.C. §§ 200)
212, which establishes that the Government has an irrevocable paid up license to have patents practiced on its behalf, where it has)

justiciable issues remain. First, she continues to contest her obligation to assign her interest in the invention to defendant, contending that the Bayh–Dole Act, )
35 U.S.C. § 200)
212, does not apply to her personally but only to the university. She maintains that the university was required to obtain an)

complaint under Rule 12(b)(6) and properly denied his subsequent motions to amend and for reconsideration. First, several of Vartanian's claims are based on )
35 U.S.C. §§ 200)
212 (1994)''Patent Rights in Inventions Made with Federal Assistance.''These sections require that certain provisions regarding the disclosure of inventions and)

Dole Act, which set the stage for modern university licensing went into effect less than six months before the '634 patent's filing date.See )
35 U.S.C. § 200 (1994))
[16] The district court also held Cyanamid liable to the University for unjust enrichment. Cyanamid does not argue that the district)

the case to the United States District Court for the Southern District of New York invoking federal question jurisdiction based on the Technology Transfer Act. )
35 U.S.C. § 200 et seq)
. The Technology Transfer Act allows AUI, a nonprofit New York corporation, to manage Brookhaven under contract with the Department of)

also hindered from developing applied research products by its inability to obtain patents for its basic research products until 1980 when the federal patent law ()
35 U.S.C. § 200 et seq)
.) was amended to allow and encourage basic research organizations to patent their basic research products and enter into agreements similar)

did not apply to animal rights group's action seeking access to unfunded university grant proposal, where no information described in Act was subject to disclosure. )
35 U.S.C.A. §§ 200)
205[24]326 Records 326II Public Access 326II(B) General Statutory Disclosure Requirements 326 53 Matters Subject to Disclosure; Exemptions 326 55)

360 (S.D.N.Y.1992), where state law third party beneficiary and breach of contract claims necessarily depended on an interpretation of the 1980 Bayh–Dole Act, )
35 U.S.C. § 200 et. seq)
., none of the elements of the plaintiffs' antitrust claims ''necessarily depend'' on federal law. In this case, ''federal law provides)

moreover, directs AUI to grant licenses for these patents to private concerns in order to exploit the commercial potential of the underlying technologies.See also )
35 U.S.C. §§ 200)
et seq. To facilitate this mission, AUI's Office of Technology Transfer (''OTT'') conducts an Outreach Program, by which it disseminates information to)

under section 5908; whether section 5908 applies to Cedars; whether section 5908 is superseded by chapter 18 of Title 35 of the United States Code, )
35 U.S.C. §§ 200)
212 (1988)35 U.S.C. ch. 18); and whether the Determination was unlawfully issued.After considering Cedars' complaint and the parties' various motions)

F.2d 896, 898 (9th Cir.1986)2. Application of Standard Defendant alleges three causes of action in its counterclaim: (1) constructive trust based on )
35 U.S.C. § 200, et seq)
. (2) breach of written contract; and (3) declaratory judgment. The court must determine whether each states a cognizable legal theory)

It is with these standards in mind that the Court reviews the arguments of Alza and Marion Merrell Dow.2. Reconsideration of the Applicability of )
35 U.S.C. §§ 200)
04 The Court ruled that )
sections 200)
04 do not apply to the '652 patent. In support of this ruling, the Court)

licensed by regents of University of California was invalid and not infringed. West's Ann.Cal. Const. Art. 9, § 9(a, c, f); U.S.C.A. Const.Amend. 11 )
35 U.S.C.A. §§ 200)
204 202(c)[4]170B Federal Courts 170BV Suits Against States; Eleventh Amendment and Sovereign Immunity 170B 2372 Exceptions to Immunity 170B)

expended significant resources to further develop laser angioplasty. Finally, Cedars claims that 42 U.S.C. § 5908 is not applicable to this situation because another statute, )
35 U.S.C. §§ 200)
, et seq., takes precedence since there is no ''funding agreement'' in this case.Cedars' complaint alleges two causes of action: (1) to)

IPA were modified by the 1980 Bayh–Dole Act. (Act of Dec. 12, 1980, Pub.L. 96–517, § 6(a), 94 Stat. 3019, codified at )
35 U.S.C. § 200 et seq)
. The Bayh–Dole Act grants non-profit organizations exclusive title to inventions developed through federal funding, and allows them to)

exhaustion requirement and obtain judicial review by urging that government did not possess rights in the invention and was without authority to grant the license. )
35 U.S.C.A. §§ 200)
212 202(a, c, e)[2]291 Patents 291III Persons Entitled to Patents 291III(A) In General 291 853 k. Public employees)

An Act to Amend the Patent and Trademark Laws,''Pub.L. No. 96–517, 94 Stat. 3015 (1980) (§ 6(a) of which is codified at )
35 U.S.C. §§ 200)
11 We discuss both the terms of the license agreement and 35 U.S.C. § 207(a)(2) in greater detail below.Opposing)

L-3 Communications Corporation v. Jaxon Engineering & Maintenance, Inc.

2015 IER Cases 190,482, 190482+

(NO. 10-CV-02868-MSK-KMT )

claim challenging the determination with the Army Corps of Engineers or challenging the letter as a final agency decision before the Court of Federal Claims. )
35 U.S.C.A. § 201(c)(1)
)41 U.S.C.A. § 7101 et seq.48 C.F.R. § 252.227-7038(d)(1)(ii)[19]29T Antitrust and Trade)

the importance of symmetry in the statutory scheme's coverage of patented products that both retain the benefit of a provision in 35 U.S.C. § 156 )
section 201)
of the Hatch–Waxman Act) and the disadvantage of § 271(e)(1) (section 202 of the Hatch–Waxman Act), see Eli Lilly, 496)

15.)On September 26, 2011, the Court issued an opinion and order, in which it noted that Plaintiff had challenged O.R.C. § 3345.14 and )
35 U.S.C. § 201 et seq)
., statutes which required that research produced at universities became the intellectual property of those universities, as violative of the Fifth)

all rights to inventions, discoveries, and patents resulting from a state university research facility becomes the property of that university. Additionally, the ''Bayh–Dole Act'', )
35 U.S.C. § 201 et seq)
. gives universities control of intellectual property arising from federally funded research.(Doc. 46 at 15–16.) Defendants argue that, under)

Alzheimer's Institute of America, Inc. v. Avid Radiopharmaceuticals

WL 2175210, at *4 (June 6, 2011)aff'g 583 F.3d 832 (Fed.Cir.2009) There, the Court found that the Bayh–Dole Act of 1980, )
35 U.S.C. §§ 201(c)(e)
)202(a), which allocates rights in federally funded inventions between federal contractors and the government, did not contain unambiguous vesting)

the ′007 patent A. The Bayh–Dole Act The Bayh–Dole Act applies only to a ''subject invention'' of the government-funded research project. See )
35 U.S.C. § 201(e))
A ''subject invention'' is any invention of the ''contractor'' that was ''conceived or first actually reduced to practice in the performance)

of Constitutional Question'' (Doc. 7), in which she stated that she wished to challenge the constitutionality under the Fifth Amendment of the Bayh–Dole Act, )
35 U.S.C. § 201 et seq)
., and O.R.C. § 3345.14, two statutes addressing the ownership of intellectual property created at universities. The Court previously found)

Board of Trustees of Leland Stanford Junior University v. Roche Molecular Systems, Inc.

563 U.S. 776, 776+ 180 L.Ed.2d 1, 1+ 79 USLW 4407, 4407+ 98 U.S.P.Q.2d 1761, 1761+ 11 Cal. Daily Op. Serv. 6795, 6795+ 2011 Daily Journal D.A.R. 8175, 8175+ 22 Fla. L. Weekly Fed. S 1069, 1069+ 68 A.L.R. Fed. 2d 617, 617+

methods while working for both university and manufacturer, in joint project, using partial federal funding that university, as federal contractor, had received for the project. )
35 U.S.C.A. §§ 201(e))
202(a)210(a)Syllabus FN* The syllabus constitutes no part of the opinion of the Court but has been prepared)

all rights to inventions, discoveries, and patents resulting from a state university research facility become the property of that university), and the ''Bayh–Dole Act'', )
35 U.S.C. § 201 et seq)
. (a federal statute giving universities control of intellectual property arising from federally funded research), as violative of the Fifth Amendment)

Kimberly-Clark Worldwide, Inc. v. First Quality Baby Products, LLC

Court will still need to hold a trial on ′067 and ′187 Patents to consider the alleged prior art, which the PTO cannot consider. See )
35 U.S.C. § 201)
311 Third, First Quality argues that a stay would not unduly prejudice or present a clear tactical disadvantage to the nonmoving party)

A subject invention is ''any invention of the [entity] conceived or first actually reduced to practice in the performance of work under a funding agreement.'' )
35 U.S.C. § 201(e))
The Act permits the entity to retain title to a subject invention by making a written election within two years of)

(NO. CIV.A08-11132GAO , CIV.A09-10832GAO )

the event that such U.S. manufacture proves to be non-viable economically, M.I.T., upon request by COMPANY, agrees to assist in seeking a waiver under )
35 U.S.C. §§ 201)
211 to allow the manufacture outside the United States for the U.S. market.Id. § 2.4.)[2] It is perhaps possible)

Wisconsin Alumni Research Foundation v. Xenon Pharmaceuticals, Inc.

87 U.S.P.Q.2d 1863, 1863+

(NO. 2007-1026 , 2007-1033 )

with Federal Assistance.''Also, the language within some of the sections of the Bayh-Dole Act suggests its provenance as a patent law. For example, )
35 U.S.C. § 201(d))
defines ''invention'' as ''any invention or discovery which is or may be patentable )
Section 201(e))
explains that a ''subject invention)

Wisconsin Alumni Research Foundation v. Xenon Pharmaceuticals, Inc.

(NO. 2007-1026 , 2007-1033 )

a patent law under which a claim may arise. At its heart, the Bayh–Dole Act concerns government funding agreements—contracts in the language of )
35 U.S.C. § 201)
—an area that is outside our section 1295(a) jurisdiction.See Bonzel v. Pfizer, Inc., 439 F.3d 1358, 1362–63 (Fed.Cir)

Board of Trustees of Leland Stanford Junior University v. Roche Molecular Systems, Inc.

368 (S.D.N.Y.2000) A ''subject invention'' is ''any invention conceived or reduced to practice in the performance of work under a funding agreement.''Id. (quoting )
35 U.S.C. § 201(e))
Courts have held that such statutory vesting in the United States defeats the patentee's presumptive title to an invention, and immediately)

Revenue Code 26 U.S.C. 501(a)); (3) any nonprofit scientific or educational organization qualified under a nonprofit organization statute of a state in this country ()
35 U.S.C. 201(j))
); or (4) any nonprofit organization under paragraphs (e)(2) or (3) of those sections if it were located in this country.37)

to any invention by the contractor developed pursuant to a government contract. For purposes of the Act, Congress has termed these inventions ''subject inventions.'' See )
35 U.S.C. § 201(d)(e) (1988)
) (defining an ''invention'' to mean ''any invention or discovery that is or may be patentable,'' and ''subject invention'' to)

of parties, or subcontract of any type entered into for the performance of experimental, developmental, or research work under a funding agreement as herein defined. )
35 U.S.C. § 201(b))
(emphasis added). Under the Act, a ''contractor'' is ''any person, small business firm, or nonprofit organization that is a party to)

(NO. 97 CIV. 1529(CM)(MDF )

In view of the foregoing, IBM contends that Hillis lacked title to assign to Thinking Machines, because he failed to file the paperwork required by )
35 U.S.C. § 201(d))
Of course, if Hillis did not have valid title, then he could not convey good title to Thinking Machines, which in)

any government contract, subcontract, grant, or cooperative agreement that funds the experimental, developmental, or research work of persons, small business firms, or nonprofit organizations. Se )
35 U.S.C. §§ 201)
202 Vartanian argues that § 202 allows him to pursue a cause of action against the Department of Commerce, Lura Powell, and)

(NO. CV 93-1284 H (BTM) )

within such time.35 U.S.C. § 202 (1988)Defendant alleges that the inventions disclosed in the '330 Patent are ''subject inventions'' within the meaning of )
Sections 201(e))
and 202(a) because Dr. Kohne ''conceived'' or ''reduced to practice'' the inventions while working under funding agreements with federal government agencies. Defendant)

23 Fed.R.Serv.3d 1246, 1246+ 26 U.S.P.Q.2d 1321, 1321+

agreement.6 FN6. Under § 201 a contractor is any person, small business, firm or nonprofit organization that is a party to a funding agreement. )
35 U.S.C. § 201)
Pursuant to )
§ 201)
a funding agreement is any contract, grant, or cooperative agreement entered into between any Federal agency, other than)

19 U.S.P.Q.2d 1761, 1761+

94 Stat. 3015, 3028 (1980). The statute covers inventions ''conceived or first actually reduced to practice in the performance of work under a funding agreement )
35 U.S.C. § 201(e) (1988)
) The funding agreement between SRI and the USDA was entered into in 1978 and concluded in 1980. Arguably some portions)

the amendment but were challenging provision which such rules and regulations were intended to enforce. Immigration and Nationality Act, §§ 101 et seq.,104(a) )
201 et seq)
.,212(a)(14)279 as amended 8 U.S.C.A. §§ 1101 et seq.,1104(a)1151 et seq.,1182(a)(14)1329[5]24)

100 L.R.R.M. (BNA) 3030, 3030 86 Lab.Cas. P 11,328, 11328

procedures as a preferred method for settling disputes and stabilizing the ''common law'' of the plant. LMRA s 203(d), 29 U.S.C. s 173(d) )
s 201(c))
29 U.S.C. s 171(c) (1958 ed.) Union interest in prosecuting employee grievances is clear. Such activity complements the union's status as exclusive)

(NO. 74-10 , 74-11 , 74-12 , 74-6 , 74-7 , 74-8 , 74-9 )

a prospect blasted by former President Nixon's four months' delay in nominating the Chairman and certain other members of the Board of Directors of USRA, )
§ 201(d))
They point also to an USRA press release dated August 22, 1974, a copy of which is annexed as Appendix B, showing that)

suit; state did not waive its immunity by entering into arrangements controlled by federal law and reviewable only in federal court. U.S. Const. Amend. 11 )
35 U.S.C.A. § 202(c)(7)(B)
)[4]291 Patents 291VII Patent Infringement 291VII(C) Actions 291VII(C)1 In General 291 1750 Discovery 291 1755 Scope)

AATI's PCT/US/2009 Application; U.S. Patent Nos. 6,874,729 7,097,137 8,517,306 8,167,242 8,567,718; and 8,864,069; and U.S. Patent Application Serial No. 14/518,348 pursuant to )
35 U.S.C. § 202)
4 and Federal Acquisition Regulation § 52.227–11 Gov't App'x at GA 228–33.FN4. The relevant portions of )
35 U.S.C)

119 U.S.P.Q.2d 1083, 1083

20(j)(1), 125 Stat. 284, 288, 328, 335 (2011); Patent Law Treaties Implementation Act of 2012, Pub. L. No. 112–211§§ 102(5) )
202(3))
126 Stat. 1527, 1531, 1536.[2]Section 120's language does not by its terms answer the question whether a later-filed application can)

(NO. CV 13-1534-SLR/SRF )

and other employees. In addition, since SRI's research is federally funded, it is required by the Bayh–Dole Act to share royalties with inventors. See )
35 U.S.C. § 202(c)(7)(B)
) The current version of SRI's royalty–sharing program has been in effect since 2008, and includes all revenue SRI)

L-3 Communications Corporation v. Jaxon Engineering & Maintenance, Inc.

(NO. 10-CV-02868-MSK-KMT )

action under terms of Act, and nothing in text of Act required funding recipient to consent to suit in federal court. U.S.C.A. Const. Amend. 11 )
35 U.S.C. § 202(d))
[26]106 Courts 106II Establishment, Organization, and Procedure 106II(G) Rules of Decision 106 88 Previous Decisions as Controlling or as)

Alzheimer's Institute of America, Inc. v. Avid Radiopharmaceuticals

2011)aff'g 583 F.3d 832 (Fed.Cir.2009) There, the Court found that the Bayh–Dole Act of 1980, 35 U.S.C. §§ 201(c)(e) )
202(a))
, which allocates rights in federally funded inventions between federal contractors and the government, did not contain unambiguous vesting language. Id. at *7. Rather, the)

200 et seq. The Bayh–Dole Act requires title to inventions flowing from government-funded research to remain with the government in certain circumstances. See )
35 U.S.C. § 202(a))
In other circumstances, the Act makes available a procedure for nonprofit organizations and other ''contractors'' to follow if they wish to)

Board of Trustees of Leland Stanford Junior University v. Roche Molecular Systems, Inc.

563 U.S. 776, 776+ 180 L.Ed.2d 1, 1+ 79 USLW 4407, 4407+ 98 U.S.P.Q.2d 1761, 1761+ 11 Cal. Daily Op. Serv. 6795, 6795+ 2011 Daily Journal D.A.R. 8175, 8175+ 22 Fla. L. Weekly Fed. S 1069, 1069+ 68 A.L.R. Fed. 2d 617, 617+

university and manufacturer, in joint project, using partial federal funding that university, as federal contractor, had received for the project. 35 U.S.C.A. §§ 201(e) )
202(a))
210(a)Syllabus FN* The syllabus constitutes no part of the opinion of the Court but has been prepared by the Reporter of Decisions)

each subject invention to the Federal agency within a reasonable time after it becomes known to contractor personnel responsible for the administration of patent matters.'' )
35 U.S.C. § 202(c)(1)
) A subject invention is ''any invention of the [entity] conceived or first actually reduced to practice in the performance of)

Board of Trustees of Leland Stanford Junior University v. Roche Molecular Systems, Inc.

249 Ed. Law Rep. 612, 612+ 92 U.S.P.Q.2d 1442, 1442+

(NO. 2008-1509 , 2008-1510 )

to inventions arising from federally supported research or development under certain circumstances, does not automatically void ab initio an inventors' rights in government-funded inventions. )
35 U.S.C.A. § 202)
[23]291 Patents 291VI Patent Rights and Duties 291VI(F) Government Rights and Duties as to Inventions 291 1532 Inventions by Government)

237 Ed. Law Rep. 43, 43 28 IER Cases 218, 218

inventors and CPS as assignee but were silent with respect to the University.In November 1999, the University acted pursuant to the Bayh–Dole Act, )
35 U.S.C. § 202(c)(2)
)1 which relates to the receipt of federal funds for government-funded research, to elect title to the PET/CT)

University elected title to the PET/CT scanner invention, pursuant to the provisions of the Bayh-Dole Act relating to the receipt of federal funds, )
35 U.S.C. § 202(c)(2)
) This election of title is reflected on the NIH's website. The NIH has never challenged the University's title to the)

Board of Trustees of Leland Stanford Junior University v. Roche Molecular Systems, Inc.

to government explicitly electing to retain title in patents, and Bayh–Dole Act mandated that university be given superior right to retain title to patents. )
35 U.S.C.A. § 202(d))
37 C.F.R. § 401.1(b)[27]291 Patents 291VI Patent Rights and Duties 291VI(F) Government Rights and Duties as)

Central Admixture Pharmacy Services, Inc. v. Advanced Cardiac Solutions, P.C.

82 U.S.P.Q.2d 1293, 1293+

wrote to NIH to request that it waive patent rights in the application so that he could pursue the application in his personal capacity. See )
35 U.S.C. § 202(d))
(allowing agencies to grant such requests). NIH granted that waiver on September 23, 1987, on the condition that ''the inventor shall)